Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Brachytherapy ; 15(1): 1-11, 2016.
Article in English | MEDLINE | ID: mdl-26561277

ABSTRACT

PURPOSE: To update brachytherapy recommendations for pretreatment evaluation, treatment, and dosimetric issues for thoracic brachytherapy for lung cancer. METHODS AND MATERIALS: Members of the American Brachytherapy Society with expertise in thoracic brachytherapy updated recommendations for thoracic brachytherapy based on literature review and clinical experience. RESULTS: The American Brachytherapy Society consensus guidelines recommend the use of endobronchial brachytherapy for disease palliation in patients with central obstructing lesions, particularly in patients who have previously received external beam radiotherapy. The use of interstitial implants after incomplete resection may improve outcomes and provide enhanced palliation. Early reports support the use of CT-guided intratumoral volume implants within clinical studies. The use of brachytherapy routinely after sublobar resection is not generally recommended, unless within the confines of a clinical trial or a registry. CONCLUSIONS: American Brachytherapy Society recommendations for thoracic brachytherapy are provided. Practitioners are encouraged to follow these guidelines and to develop further clinical trials to examine this treatment modality to increase the evidence base for its use.


Subject(s)
Brachytherapy , Consensus , Lung Neoplasms/radiotherapy , Palliative Care , Brachytherapy/methods , Humans , Patient Selection , Radiotherapy, Adjuvant , United States
2.
Prostate Cancer Prostatic Dis ; 18(2): 96-103, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25687401

ABSTRACT

Permanent radioactive seed implantation provides highly effective treatment for prostate cancer that typically includes multidisciplinary collaboration between urologists and radiation oncologists. Low dose-rate (LDR) prostate brachytherapy offers excellent tumor control rates and has equivalent rates of rectal toxicity when compared with external beam radiotherapy. Owing to its proximity to the anterior rectal wall, a small portion of the rectum is often exposed to high doses of ionizing radiation from this procedure. Although rare, some patients develop transfusion-dependent rectal bleeding, ulcers or fistulas. These complications occasionally require permanent colostomy and thus can significantly impact a patient's quality of life. Aside from proper technique, a promising strategy has emerged that can help avoid these complications. By injecting biodegradable materials behind Denonviller's fascia, brachytherpists can increase the distance between the rectum and the radioactive sources to significantly decrease the rectal dose. This review summarizes the progress in this area and its applicability for use in combination with permanent LDR brachytherapy.


Subject(s)
Absorbable Implants , Brachytherapy/adverse effects , Prostatic Neoplasms/radiotherapy , Humans , Male , Prostate/pathology , Prostate/radiation effects , Prostatic Neoplasms/pathology , Radiation, Ionizing , Rectum/pathology , Rectum/radiation effects , Treatment Outcome
4.
Int J Immunopathol Pharmacol ; 27(1): 97-102, 2014.
Article in English | MEDLINE | ID: mdl-24674683

ABSTRACT

Osteopontin (OPN) is an extracellular matrix protein implicated in bone remodeling, but it presents also pro-inflammatory and pro-fibrotic properties. OPN expression also occurs upon exposure of cells to classical mediators of acute inflammation such as tumor necrosis growth factor alpha (TNF-alpha) and interleukin-1 beta (IL-1beta), as well as fibrogenic cytokines such as transforming growth factor beta (TGF-beta), although a detailed understanding of these regulatory pathways is still unknown. Plasma OPN levels in both limited and diffuse systemic sclerosis patients (lSSc and dSSc) were statistically higher compared to those of control subjects. Immunohistology demonstrated that high TGF-beta levels, alpha smooth muscle actin (alphaSMA) levels and consequently high OPN levels were found in the affected skin of sclerodermic patients (lSSc and dSSc) compared to levels found in healthy skin. In order to better understand how OPN interferes with the fibrotic process, healthy skin fibroblasts were treated for 24 and 48 hours with bleomycin and with endothelin-1 (ET-1) plus TGF-beta in order to induce the fibrogenesis. After 48 hours of stimulation, healthy treated fibroblasts showed statistically increased alphaSMA levels (index of differentiation into myofibroblasts) and simultaneously statistically increased OPN levels compared to healthy untreated ones. This study demonstrates that OPN levels increase simultaneously with the increasing of alphaSMA levels, therefore it is reasonable to hypothesize that OPN interferes in the pathogenesis of Systemic Sclerosis in the early stage of fibroblast differentiation process.


Subject(s)
Actins/metabolism , Cell Differentiation , Fibroblasts/metabolism , Osteopontin/metabolism , Scleroderma, Systemic/etiology , Bleomycin/pharmacology , Blotting, Western , Case-Control Studies , Cells, Cultured , Endothelin-1/pharmacology , Enzyme-Linked Immunosorbent Assay , Female , Fibroblasts/drug effects , Fibroblasts/pathology , Humans , Immunohistochemistry , Middle Aged , Osteopontin/blood , Scleroderma, Systemic/blood , Scleroderma, Systemic/metabolism , Scleroderma, Systemic/pathology , Transforming Growth Factor beta/pharmacology
5.
Scand J Rheumatol ; 41(5): 391-5, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23043266

ABSTRACT

OBJECTIVES: Relaxin (RLX) is involved in extracellular matrix and collagen remodelling. The therapeutic role of the circulating isoform RLX-2 as an anti-fibrotic factor in systemic sclerosis (SSc) has been investigated. Several RLX family peptide receptors (RXFPs) are recognized in humans: RLX-2 is a ligand for RXFP1/LGR7 and RXFP2/LGR8. The aim of this study was to define the pattern of expression of LGR7 in different types of human skin cells and to compare normal skin with lesional and unaffected skin from patients with limited SSc (lSSc). METHOD: We analysed RXFP1 immunolocalization on skin biopsies and cultured fibroblasts from lSSc patients and control subjects. Western blot analysis was carried out on fibroblast lysates. RESULTS: RXFP1 showed cytoplasmic localization on skin cells from control subjects and non-lesional skin from lSSc patients: keratinocytes, gland epithelial cells, endothelium, smooth muscle cells, and fibroblasts. Immunogold electron microscopy confirmed a diffuse epithelial cytoplasmic localization of RXFP1. A substantially lower RXFP1 expression was observed in scleroderma skin, with a lack of staining in most cells. Occasional weak reactivity was observed in cultured scleroderma fibroblasts, while control fibroblasts showed a diffuse cytoplasmic immunoreactivity of RXFP1, confirmed by Western blot analysis. CONCLUSIONS: The decreased cellular expression of RLX-2 receptor RXFP1 in scleroderma skin might represent a pro-fibrotic factor and contribute to the substantial inefficacy of RLX treatment in SSc, as reported in the literature. The pathophysiology of the decrease in RXFP1 may be linked to high RLX-2 serum levels previously detected in SSc, but it has yet to be elucidated.


Subject(s)
Fibroblasts/metabolism , Receptors, G-Protein-Coupled/metabolism , Receptors, Peptide/metabolism , Scleroderma, Systemic/metabolism , Skin/metabolism , Aged , Cells, Cultured , Female , Fibroblasts/pathology , Fibrosis/metabolism , Fibrosis/pathology , Humans , Middle Aged , Scleroderma, Systemic/pathology , Skin/pathology
6.
Cell Death Differ ; 19(3): 488-500, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21921940

ABSTRACT

TRAF and TNF receptor-associated protein (TTRAP) is a multifunctional protein that can act in the nucleus as a 5'-tyrosyl DNA phosphodiesterase and in the cytoplasm as a regulator of cell signaling. In this paper we show that in response to proteasome inhibition TTRAP accumulates in nucleolar cavities in a promyelocytic leukemia protein-dependent manner. In the nucleolus, TTRAP contributes to control levels of ribosomal RNA precursor and processing intermediates, and this phenotype is independent from its 5'-tyrosyl DNA phosphodiesterase activity. Our findings suggest a previously unidentified function for TTRAP and nucleolar cavities in ribosome biogenesis under stress.


Subject(s)
Cell Nucleolus/metabolism , Nuclear Proteins/metabolism , Proteasome Inhibitors , RNA Processing, Post-Transcriptional/physiology , RNA, Ribosomal/metabolism , Ribosomes/metabolism , Signal Transduction/physiology , Transcription Factors/metabolism , Tumor Suppressor Proteins/metabolism , Cell Line, Tumor , Cell Nucleolus/genetics , DNA-Binding Proteins , HEK293 Cells , Humans , Nuclear Proteins/genetics , Phosphoric Diester Hydrolases , Promyelocytic Leukemia Protein , Proteasome Endopeptidase Complex/genetics , Proteasome Endopeptidase Complex/metabolism , RNA, Ribosomal/genetics , Ribosomes/genetics , Stress, Physiological/physiology , Transcription Factors/genetics , Tumor Suppressor Proteins/genetics
8.
Carcinogenesis ; 30(6): 960-7, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19386580

ABSTRACT

Calpains are cysteine proteases comprising members ubiquitously expressed in human tissues and other tissue-specific isoforms. Alterations of calpain 3 (p94), the muscle-specific isoform that contains three peculiar sequences (NS, IS1 and IS2), are strictly associated to the limb-girdle muscular dystrophy type 2A, in which a myonuclear apoptosis has been documented. Our recent demonstration of a proapoptotic role of ubiquitous calpains in drug-induced apoptosis of melanoma cells prompted us to investigate the expression of calpain 3 in human melanoma cell lines undergoing apoptosis and in melanocytic lesions. In melanoma cell lines, we have identified two novel splicing variants of calpain 3 (hMp78 and hMp84): they have an atypical initiation exon and a putative nuclear localization signal, the shorter one lacks IS1 inset and both proteins are extremely unstable. Virtually, both isoforms (prevalently as cleavage forms) are localized in cytoplasm and in nucleoli. In cisplatin-treated preapoptotic cells, an increase of both transcription and autoproteolytic cleavage of the novel variants is observed; the latter event is prevented by the inhibitor of ubiquitous calpains, calpeptin, which is also able to protect from apoptosis. Interestingly, among melanocytic lesions, the expression of these novel variants is significantly downregulated, compared with benign nevi, in the most aggressive ones, i.e. in vertical growth phase melanoma and, even more, in metastatic melanoma cells, characterized by invasiveness properties and usually highly resistant to apoptosis. On the whole, our observations suggest that calpain 3 variants can play a proapoptotic role in melanoma cells and its downregulation, as observed in highly aggressive lesions, could contribute to melanoma progression.


Subject(s)
Antineoplastic Agents/pharmacology , Calpain/metabolism , Cisplatin/pharmacology , Melanoma/metabolism , Muscle Proteins/metabolism , Nevus/metabolism , Skin Neoplasms/metabolism , Alternative Splicing , Apoptosis , Biopsy , Calpain/antagonists & inhibitors , Cell Line, Tumor , Cell Nucleolus/metabolism , Cytoplasm/metabolism , Dipeptides/pharmacology , Dysplastic Nevus Syndrome/metabolism , Gene Expression Regulation, Neoplastic , Humans , Melanoma/pathology , Muscle Proteins/antagonists & inhibitors , Neoplasm Metastasis , RNA, Messenger/metabolism , Skin Neoplasms/pathology
9.
Cell Death Differ ; 16(3): 428-38, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19023331

ABSTRACT

Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). This gene encodes for an atypical peroxiredoxin-like peroxidase that may act as a regulator of transcription and a redox-dependent chaperone. Although large gene deletions have been associated with a loss-of-function phenotype, the pathogenic mechanism of several missense mutations is less clear. By performing a yeast two-hybrid screening from a human fetal brain library, we identified TRAF and TNF receptor-associated protein (TTRAP), an ubiquitin-binding domain-containing protein, as a novel DJ-1 interactor, which was able to bind the PD-associated mutations M26I and L166P more strongly than wild type. TTRAP protected neuroblastoma cells from apoptosis induced by proteasome impairment. In these conditions, endogenous TTRAP relocalized to a detergent-insoluble fraction and formed cytoplasmic aggresome-like structures. Interestingly, both DJ-1 mutants blocked the TTRAP protective activity unmasking a c-jun N-terminal kinase (JNK)- and p38-MAPK (mitogen-activated protein kinase)-mediated apoptosis. These results suggest an active role of DJ-1 missense mutants in the control of cell death and position TTRAP as a new player in the arena of neurodegeneration.


Subject(s)
Apoptosis/physiology , Inclusion Bodies/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Mutation, Missense , Nuclear Proteins/metabolism , Oncogene Proteins/genetics , Parkinson Disease , Transcription Factors/metabolism , Antineoplastic Agents/metabolism , Brain Neoplasms , Cell Line , DNA-Binding Proteins , Dopamine/metabolism , Enzyme Activation , Humans , Intracellular Signaling Peptides and Proteins/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Leupeptins/metabolism , Neuroblastoma , Nuclear Proteins/genetics , Oncogene Proteins/metabolism , Oxidative Stress , Parkinson Disease/genetics , Parkinson Disease/metabolism , Phosphoric Diester Hydrolases , Protein Binding , Protein Deglycase DJ-1 , Substantia Nigra/cytology , Substantia Nigra/metabolism , Transcription Factors/genetics , Two-Hybrid System Techniques , p38 Mitogen-Activated Protein Kinases/metabolism
10.
G Ital Med Lav Ergon ; 29(4): 898-902, 2007.
Article in English | MEDLINE | ID: mdl-18409262

ABSTRACT

The Authors, after a survey of the latest experimental and epidemiological studies concerning the possible role of crystalline silica in lung carcinogenicity, examine the cases acknowledged by the INAIL in Genoa concerning subjects suffering from silicosis who, thereafter, developed a lung cancer in the period 1979 - 2004. Distribution of the degree of disability, of the length of occupational exposure to silica, of the workers' age at the time of death and of the different fields of activity have been tested; smoking habits and histological classification of the neoplasms have also been assessed, when available. Our data seem to agree with the point of view of the Authors who so far have expressed perplexities about the role played by silica in lung carcinogenesis, especially if associated with the exposure to powerful carcinogenic agents such as cigarette smoke. At present we share the opinion of those who think that a final regulation should be delayed up to the time when it will be possible to identify the occupational source of silica with such characteristic as to make it actually carcinogenic.


Subject(s)
Adenocarcinoma/epidemiology , Carcinoma, Squamous Cell/epidemiology , Lung Neoplasms/epidemiology , Occupational Exposure/adverse effects , Registries , Silicon Dioxide/adverse effects , Silicosis/complications , Adenocarcinoma/mortality , Age Factors , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Humans , Italy/epidemiology , Lung Neoplasms/mortality , Middle Aged , Risk Factors , Silicosis/epidemiology , Smoking/adverse effects , Time Factors
11.
Int J Artif Organs ; 28(10): 1039-50, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16288443

ABSTRACT

BACKGROUND: Since 1990 our group has been using extracorporeal circulation to ozonate blood by an original method, known as extracorporeal blood oxygenation and ozonation (EBOO), with the aim of amplifying the results observed with ozone autohemotherapy. OBJECTIVE: To verify the hypothesis that EBOO improves the skin lesions typical of peripheral artery disease (PAD) patients. METHODS: Twenty-eight patients with PAD were randomized to receive EBOO or intravenous prostacyclin in a controlled clinical trial. The primary efficacy parameters were regression of skin lesions and pain,and improvement in quality of life and vascularisation. RESULTS: Patients treated with EBOO showed highly significant regression of skin lesions with respect to patients treated with prostacyclin. Other parameters that were significantly different in the two groups of patients were pain,pruritus, heavy legs and well-being. No significant differences in vascularisation of the lower limbs before and after treatment were found in either group. No side effects or complications were recorded during the 210 EBOO treatments. CONCLUSION: EBOO was much more effective than prostacyclin for treating skin lesions in PAD patients and also had a positive effect on patient general condition without any apparent change in arterial circulation. This suggests other mechanisms of action of EBOO.


Subject(s)
Arterial Occlusive Diseases/therapy , Epoprostenol/therapeutic use , Extracorporeal Membrane Oxygenation/methods , Ozone/therapeutic use , Peripheral Vascular Diseases/therapy , Skin Ulcer/prevention & control , Aged , Aged, 80 and over , Arterial Occlusive Diseases/complications , Female , Humans , Male , Middle Aged , Peripheral Vascular Diseases/complications , Severity of Illness Index , Skin Ulcer/etiology , Treatment Outcome
12.
Clin Exp Dermatol ; 30(4): 385-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15953077

ABSTRACT

Composite cutaneous haemangioendothelioma is a recently characterized rare tumour of vascular origin. As there are only a few reported cases, the biological behaviour of the tumour and appropriate therapeutic approaches are not yet clear. We report a new case of composite cutaneous haemangioendothelioma and discuss prognostic and therapeutic aspects of this neoplasm.


Subject(s)
Foot Diseases/diagnosis , Hemangioendothelioma/diagnosis , Skin Neoplasms/diagnosis , Female , Foot Diseases/pathology , Foot Diseases/surgery , Hemangioendothelioma/pathology , Hemangioendothelioma/surgery , Humans , Middle Aged , Prognosis , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Toes
14.
Toxicology ; 208(3): 389-98, 2005 Mar 30.
Article in English | MEDLINE | ID: mdl-15695024

ABSTRACT

The ability of cadmium to disrupt calcium homeostasis has been known since a long time, but the precise cellular targets of its toxic action are still debated. A great problem in the interpretation of data has been associated with the ability of cadmium to strongly bind traditional calcium probes. Aequorin, the well-characterized calcium-sensitive photoprotein, was used as intracellular calcium indicator during cadmium injury in NIH 3T3 murine fibroblasts. NIH 3T3 cells were transfected with a cDNA construct containing aequorin fused to a truncated glutamate receptor, which directs the probe to the outer surface of intracellular membranes. At first, we tested if different cadmium concentrations were able to modify the rate of light emission by aequorin showing that cadmium concentrations <15 microM were ineffective on aequorin luminescence. Hence, aequorin chimeras revealed as a useful tool in the analyses of Cd2+/Ca2+ interference. To directly investigate the role of Cd2+ in Ca2+ homeostasis, we have started to selectively measure the free Ca2+ concentration in different cell compartments. Here, we report that cadmium reduces the transient free calcium signal after stimulation of cells with bradykinin. Further studies are in progress to clarify the role of mitochondria and endoplasmic reticulum in cadmium-induced alterations of Ca2+ homeostasis in order to link signal transduction modifications with the onset of apoptosis induced by cadmium exposure.


Subject(s)
Aequorin/metabolism , Cadmium/toxicity , Calcium/analysis , Luminescent Agents/pharmacology , Recombinant Fusion Proteins/metabolism , Aequorin/genetics , Animals , Apoptosis/drug effects , Cadmium/metabolism , Calcium/metabolism , Dose-Response Relationship, Drug , Luminescent Agents/chemistry , Mice , Microscopy, Phase-Contrast , NIH 3T3 Cells , Recombinant Fusion Proteins/genetics , Spectrophotometry, Atomic , Time Factors
15.
G Ital Nefrol ; 21 Suppl 30: S177-80, 2004.
Article in Italian | MEDLINE | ID: mdl-15750980

ABSTRACT

PURPOSE: Hemodiafiltration (HDF) has high removal rates of low and middle-high molecular weight uremic toxins. We aimed to understand the efficacy and the safety in correcting on-line HDF acidosis. We compared two infusion methods of on-line prepared solution in HDF: HDF with an infusion solution produced from dialysate (HDF-OL) and HDF with a solution from patient ultrafiltrate after regeneration (HFR). METHODS: Eleven patients (four males, seven females) age 66 +/- 10 yrs, dialysis age 5.0 +/- 1.3 yrs, on anuria had two dialysis methods for the 1st session of the week, one HDF-OL and one HFR in 2 different weeks. In HDF-OL a high-flux polysulphone dialyser 1.8 m2 was used, in HFR a two-stage filter was used: polyetersulfone 0.7 m2 + SMC 1.95 m2 and a sorbent cartridge Selecta plus (Bellco) to regenerate the ultrafiltrate. HCO3- in the dialysis bath was 32 mmol/L. RESULTS: Plasma bicarbonates, before dialysis were 21.6 +/- 2.1 mmol/L on HDF-OL and 21.5 +/- 3.3 on HFR (p=ns), at the end they were 27.5 +/- 1.8 mmol/L on HDF-OL and 27.8 +/- 1.2 mmol/L on HFR (p=ns). On HDF-OL bicarbonates reached a plateau at mid session: 27 +/- 1.2, 27.5 +/- 1.2, 27.5 +/- 1.8 to 120, 180 and 240 min respectively. On HFR the plateau was reached more slowly: 26.1 +/- 1.9, 27.1 +/- 1.4, 27.8 +/- 1.2 with the same times. CONCLUSIONS: HFR-OL and HFR efficaciously corrected acidosis in a 4-h dialysis session. The same results, statistically and clinically, were achieved with infusion solution derived from dialysate and from solution from regenerated ultrafiltrate. In the latter, it was interesting that the global quality of the infusion solution was obtained from a close circuit from the patient ultrafiltrate.


Subject(s)
Bicarbonates/blood , Hemodiafiltration/methods , Hemodialysis Solutions/administration & dosage , Aged , Female , Humans , Male
16.
J Eur Acad Dermatol Venereol ; 17(1): 28-33, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12602964

ABSTRACT

BACKGROUND: The term 'common mole', often used to describe a subset of benign pigmented skin lesions, is traditionally defined on the basis of morpho-chromatic features. In recent years, certain research groups have developed equipment and methods, such as digital dermoscopy analysis, that enable objective evaluation of pigmented skin lesions. OBJECTIVE: In this study we use a digital dermoscopy analyser trained for the recognition of pigmented skin lesions to compare the subjective definition of 'common' and the mathematical concept of 'close to the mean of measurements'. METHODS: A subset (100) of digital images of flat pigmented lesions, obtained in daily practice, were classified by trained and non-expert clinicians as common moles (60) or clear-cut melanoma (40), and processed with a DB-Mips analyser. The resulting parameters, validated by a classifier, were used to evaluate Hotelling's T2 multivariate distances from the mean. RESULTS: 'Common' moles could not be clearly defined in terms of closeness to the means of objectively evaluated parameters. Their diagnosis indudes many other evaluations and clusters of variables. CONCLUSION: The clinical semantics of the term 'common' does not conform to any unambiguous mathematical definition.


Subject(s)
Melanoma/pathology , Nevus/pathology , Skin Neoplasms/pathology , Diagnosis, Computer-Assisted , Discriminant Analysis , Humans , Luminescent Measurements , Skin/pathology
18.
Br J Dermatol ; 146(3): 399-408, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11952539

ABSTRACT

BACKGROUND: Telomere length is correlated with cellular ageing and immortalization processes. In some human cancers telomere length measurement has proved to be of diagnostic and prognostic value. Results comparable with the traditional terminal restriction fragment length determination by Southern blotting have been obtained in metaphase and interphase cells in some studies by fluorescence in situ hybridization (FISH) analysis; FISH additionally allows for the quantification of telomeres at the cellular level. OBJECTIVES: In this study, 32 melanocytic lesions were analysed by FISH, aiming at investigating possible telomere differences among various benign and malignant lesions and correlation with telomerase activity (TA) level. METHODS: FISH was performed on paraffin sections from six common naevi, eight Spitz naevi, 12 melanomas, six melanoma metastases and nine control samples of normal skin. Telomere mean maximum diameter (Feret max), area and number per nuclear area were calculated by image analysis on fluorescent images elaborated through KS400 and in situ imaging system (ISIS) for FISH analysis programs. Mean TA level was also calculated in all lesions and correlated with telomere parameters. RESULTS: Telomere number per nuclear area was significantly lower in melanomas and metastases than in benign common and Spitz naevi and in control skin (7 small middle dot24 +/- 3.3; 6.11 +/- 3 vs. 14.46 +/- 5.6; 16.92 +/- 7.8; and 12.59 +/- 3.4, respectively; P < 0 .001). No significant differences were found for the other telomere parameters. In common and Spitz naevi, telomere number was positively correlated with Feret max (P = 0.046 and P < 0.0001, respectively). TA was significantly higher in melanomas and metastases than in the other groups (70.18 +/- 25.2; 105.07 +/- 30 vs. 2.16 +/- 2.4; 2 .99 +/- 2.1; 2 +/- 1.2, respectively; P< or = 0. 001) and it was inversely correlated with telomere number per nuclear area in melanomas (P = 0.0041). No other significant correlations were found. CONCLUSIONS: Encouraging results have been obtained from quantitative telomere evaluation in the diagnosis of melanocytic lesions, although an analysis of a larger number of cases would be necessary to provide more reliable data. An extreme shortening of some telomeres probably results in the decrease of telomeric signals and the lower mean number of detectable telomeres in melanomas and metastases. In melanomas, telomere number per nuclear area is also inversely correlated with TA levels. Quantitative FISH of melanocytic lesions could give more specific information at the cellular level in telomere and telomerase fields of investigation.


Subject(s)
Nevus/ultrastructure , Skin Neoplasms/ultrastructure , Telomere/ultrastructure , Case-Control Studies , Humans , Image Processing, Computer-Assisted , In Situ Hybridization, Fluorescence , Melanoma/enzymology , Melanoma/secondary , Melanoma/ultrastructure , Neoplasm Proteins/metabolism , Nevus/enzymology , Nevus, Pigmented/enzymology , Nevus, Pigmented/ultrastructure , Skin Neoplasms/enzymology , Skin Neoplasms/secondary , Telomerase/metabolism
19.
Minerva Ginecol ; 53(5): 363-6, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11550003

ABSTRACT

Two cases of vulvar Paget's disease are described in two women aged 75 and 60 years, with onset several years earlier as eczema-like manifestations, and evolving into erosive, slightly infiltrative lesions. In both cases immunohistochemical examination revealed positivity for cytokeratins CK7 and CK20. This finding suggested the diagnosis of primitive vulvar Paget's disease, a relatively benign form, unlike the aggressive and rapidly progressive secondary vulvar Paget's disease.


Subject(s)
Intermediate Filament Proteins/biosynthesis , Keratins/biosynthesis , Paget Disease, Extramammary/metabolism , Vulvar Neoplasms/metabolism , Aged , Female , Humans , Keratin-20 , Keratin-7 , Middle Aged
20.
Arch Toxicol ; 75(6): 313-20, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11570688

ABSTRACT

We investigated the induction of apoptosis by cadmium in NIH 3T3 murine fibroblasts. Apoptosis was triggered effectively by 10 microM CdCl2 within 24 h, under which conditions cell viability was reduced by 50%. Cadmium-induced apoptosis was demonstrated by both morphological and biochemical analysis. We have shown that cadmium concentrations of 5-20 microM caused nuclear fragmentation. Moreover, internucleosomal DNA fragmentation was evoked by 10-25 microM CdCl2 within 24 h, as detected by the formation of ladder patterns in DNA electrophoresis. Since the induction of programmed cell death occurs together with modifications in the cell cycle, we examined the ability of cadmium to block cell divisions by using a 5-bromo2-deoxy-uridine incorporation assay. Our results indicate that about 40% of treated cells are blocked in G0-G1 phase when exposed to 10 microM cadmium for 27 h. Finally, we addressed the question of whether the effect of cadmium could be prevented by suppressing apoptosis. Over-expression of the anti-apoptotic protein Bcl-2 in NIH 3T3 cells protects against cadmium toxicity, thus suggesting a role for Bcl-2 in the regulation of cadmium-induced apoptosis.


Subject(s)
Apoptosis/drug effects , Cadmium/toxicity , Proto-Oncogene Proteins c-bcl-2/physiology , 3T3 Cells , Animals , Cell Survival/drug effects , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Fibroblasts/cytology , Fibroblasts/drug effects , Genetic Vectors , Histocytochemistry , Immunochemistry , Mice , Microscopy, Fluorescence , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/immunology , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...